[시장보고서]세계의 정맥 내(IV) 수액 요법 시장 : 산업 규모, 점유율, 동향, 기회 및 예측 - 서비스별, 성분별, 최종 이용 산업별, 지역별, 경쟁별(2020-2030년)

세계의 정맥 내(IV) 수액 요법 시장 : 산업 규모, 점유율, 동향, 기회 및 예측 - 서비스별, 성분별, 최종 이용 산업별, 지역별, 경쟁별(2020-2030년)

Intravenous Hydration Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service, By Component, By End-Use Industry, By Region and Competition, 2020-2030F

상품코드 : 1703330

리서치사 : TechSci Research

발행일 : 2025년 04월

페이지 정보 : 영문 185 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,681,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 8,165,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 11,877,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

정맥 내(IV) 수액 요법 세계 시장은 2024년에 32억 6,000만 달러로 평가되었으며, 예측 기간 동안 7.32%의 연평균 복합 성장률(CAGR)로 성장하여 2030년까지 49억 8,000만 달러에 달할 것으로 예상됩니다.

정맥 내(IV) 수액 요법은 정맥을 통해 사람의 혈류에 직접 수분, 전해질, 경우에 따라서는 약물을 주입하는 치료법입니다. 일반적으로 탈수 및 다양한 질환에 대처하기 위해 사용됩니다. 수액 주입은 질병, 과다 발한, 구토, 설사, 수분 섭취 부족 등으로 인한 중등도에서 중증의 탈수증을 치료하기 위해 시행되는 경우가 많습니다. 정맥주사는 체내 수분을 빠르게 보충하여 전해질 균형을 회복하고 적절한 장기 기능을 유지하도록 돕습니다. 정맥주사 요법은 위장염, 신장 감염, 요로 감염 등 특정 질환으로 인한 체액 및 전해질 불균형을 관리하는 데 도움이 될 수 있습니다. 전해질은 필수 미네랄(나트륨, 칼륨, 칼슘, 마그네슘 등)로 신경 및 근육 기능, 체액 균형, pH 조절 등 다양한 신체 기능 유지에 중요한 역할을 합니다. 정맥 수액 요법은 신장 기능 장애, 호르몬 장애, 심한 구토 및 설사 등의 질환으로 인한 전해질 불균형을 교정할 수 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	32억 6,000만 달러
시장 규모 : 2030년	49억 8,000만 달러
CAGR : 2025-2030년	7.32%
급성장 부문	의약품 부문
최대 시장	북미

주요 시장 성장 촉진요인

수술 절차 증가가 시장 성장을 주도

주요 시장 과제

규제 및 법적 고려사항

주요 시장 동향

웰빙 및 라이프스타일 용도 증가

시장 규모와 예측
- 금액별
시장 점유율과 예측
- 서비스별(면역력 업, 에너지 업, 스킨케어, 편두통, 기타)
- 성분별(의약품, 의약품 이외)
- 최종 이용 산업별(병원 및 클리닉, 웰니스 센터 및 스파, 재택 헬스케어, 기타)
- 기업별(2024년)
- 지역별
시장 맵

제6장 북미의 정맥내(IV) 수분 보급 요법 시장 전망

시장 규모와 예측
시장 점유율과 예측
북미 : 국가별 분석
- 미국
- 멕시코
- 캐나다

제7장 유럽의 정맥내(IV) 수분 보급 요법 시장 전망

시장 규모와 예측
시장 점유율과 예측
유럽 : 국가별 분석
- 프랑스
- 독일
- 영국
- 이탈리아
- 스페인

제8장 아시아태평양의 정맥내(IV) 수분 보급 요법 시장 전망

시장 규모와 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
- 중국
- 인도
- 한국
- 일본
- 호주

제9장 남미의 정맥내(IV) 수분 보급 요법 시장 전망

시장 규모와 예측
시장 점유율과 예측
남미 : 국가별 분석
- 브라질
- 아르헨티나
- 콜롬비아

제10장 중동 및 아프리카의 정맥내(IV) 수분 보급 요법 시장 전망

시장 규모와 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트(UAE)

제11장 시장 역학

성장 촉진요인
과제

제12장 시장 동향과 발전

최근 동향
제품 출시
인수합병(M&A)

제13장 PESTEL 분석

제14장 Porter의 Five Forces 분석

업계내 경쟁
신규 참여 가능성
공급업체의 힘
고객의 힘
대체품의 위협

제15장 경쟁 구도

Core IV Therapy, LLC
Cryojuvenate UK Ltd.
B. Braun Medical Inc.
Otsuka Pharmaceutical Co., Ltd.
NexGen Health Inc
JW Life Science Corporation
Amanta Healthcare Ltd
Baxter International Inc.
Drip Hydration Inc
Becton, Dickinson and Company

제16장 전략적 제안

제17장 회사 소개 및 면책조항

LSH

영문 목차

영문목차

Global Intravenous (IV) Hydration Therapy Market was valued at USD 3.26 Billion in 2024 and is expected to reach USD 4.98 Billion by 2030 with a CAGR of 7.32% during the forecast period. Intravenous (IV) Hydration Therapy is a medical treatment that involves delivering fluids, electrolytes, and sometimes medications directly into a person's bloodstream through a vein. It is commonly used to address dehydration and various medical conditions. Intravenous (IV) hydration is often employed to treat moderate to severe dehydration, which can occur due to illnesses, excessive sweating, vomiting, diarrhoea, or inadequate fluid intake. IV fluids quickly replenish the body's fluid levels, helping to restore electrolyte balance and maintain proper organ function. IV hydration therapy can help manage the fluid and electrolyte imbalances that can arise from certain illnesses, such as gastroenteritis, kidney infections, and urinary tract infections. Electrolytes are essential minerals (such as sodium, potassium, calcium, and magnesium) that play a crucial role in maintaining various bodily functions, including nerve and muscle function, fluid balance, and pH regulation. IV hydration therapy can correct imbalances in electrolyte levels, which can be caused by conditions like kidney dysfunction, hormonal disorders, or severe vomiting and diarrhoea.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 3.26 Billion
Market Size 2030	USD 4.98 Billion
CAGR 2025-2030	7.32%
Fastest Growing Segment	Medicated segment
Largest Market	North America

Key Market Drivers

Increasing Surgical Procedures Drives the Market Growth

Increasing surgical procedures drive the growth of the global Intravenous (IV) hydration therapy market primarily due to the essential role that IV hydration therapy plays in supporting patients before, during, and after surgical interventions. Surgical procedures can lead to fluid and electrolyte imbalances, making proper hydration and electrolyte management crucial for successful outcomes and patient recovery. Prior to surgery, patients often need to fast or restrict their oral fluid intake, which can lead to dehydration. IV hydration therapy is used to ensure that patients are adequately hydrated before surgery, which is important for maintaining stable blood pressure, optimal organ function, and overall patient well-being. During surgery, patients may experience fluid and electrolyte shifts due to blood loss, fluid shifts, and the effects of anaesthesia. IV hydration therapy helps maintain appropriate hydration levels and electrolyte balance, supporting the body's ability to respond to surgical stress and anaesthesia. After surgery, patients may experience nausea, vomiting, and limited oral intake, which can lead to further dehydration. IV hydration therapy is essential for supporting the recovery process, preventing complications, and facilitating the healing process. Proper hydration and electrolyte balance are key factors in reducing the risk of postoperative complications, such as infections, wound healing issues, and organ dysfunction. IV hydration therapy can help minimize these risks and improve overall patient outcomes. Adequate hydration and electrolyte balance are associated with faster healing and recovery times. IV hydration therapy can help patients regain their strength and energy more quickly after surgery, allowing them to resume normal activities sooner.

Key Market Challenges

Regulatory and Legal Considerations

Regulatory and legal considerations pose significant challenges to the global Intravenous (IV) hydration therapy market due to the need to ensure patient safety, maintain quality standards, and adhere to local and international regulations governing medical practices and the administration of medical treatments. Healthcare providers who administer IV hydration therapy need to hold the appropriate licenses and certifications to perform medical procedures. These requirements vary by jurisdiction and can involve extensive training and education. Obtaining and maintaining these credentials can be time-consuming and costly. Different healthcare professionals have varying scopes of practice when it comes to administering IV therapies. Legal and regulatory frameworks may restrict who is allowed to perform IV therapy, which can impact the availability and accessibility of the treatment.

Key Market Trends

Rise of Wellness and Lifestyle Use

In global Intravenous (IV) Hydration Therapy market, The rise of wellness and lifestyle use is a significant trend in the global Intravenous (IV) hydration therapy market. This trend involves individuals seeking IV hydration therapy not only for medical reasons but also for general wellness, lifestyle enhancement, and performance optimization. The trend has expanded the potential consumer base beyond traditional medical indications. Wellness-conscious individuals, athletes, professionals with demanding lifestyles, and those seeking quick recovery from fatigue or exertion are exploring IV hydration therapy for its perceived benefits. The trend aligns with a growing interest in holistic health and well-being. Consumers are viewing IV hydration therapy as a complementary approach to maintaining overall health, alongside other wellness practices such as diet, exercise, and stress management. Many individuals seek IV hydration therapy to boost energy levels and combat fatigue. The treatment is believed to provide a quick and efficient way to rehydrate and replenish essential nutrients, leading to improved vitality and performance. IV hydration therapy is often marketed as a way to support the immune system, particularly during times of stress, travel, or exposure to illness. Consumers may opt for IV treatments to enhance their body's defenses and well-being. IV hydration therapy is perceived as a convenient and time-efficient method of receiving hydration and nutrients. This appeals to busy individuals who seek immediate results.

Key Market Players

Core IV Therapy, LLC
Rejuvenated UK Ltd.
B. Braun Medical Inc.
Otsuka Pharmaceutical Co., Ltd.
NexGen Health Inc
JW Life Science Corporation
Amanta Healthcare Ltd
Baxter International Inc.
Drip Hydration Inc.
Becton, Dickinson and Company

Report Scope:

In this report, Global Intravenous (IV) Hydration Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intravenous (IV) Hydration Therapy Market, By Service:

Immune Boosters
Energy Boosters
Skin Care
Migraine
Others

Intravenous (IV) Hydration Therapy Market, By Component:

Medicated
Non-medicated

Intravenous (IV) Hydration Therapy Market, By End-User:

Hospitals & Clinics
Wellness Centers & Spas
Home Healthcare
Others

Intravenous (IV) Hydration Therapy Market, By region:

North America
- United States
- Canada
- Mexico
Asia-Pacific
- China
- India
- South Korea
- Australia
- Japan
Europe
- Germany
- France
- United Kingdom
- Spain
- Italy
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Intravenous (IV) Hydration Therapy Market.

Available Customizations:

Global Intravenous (IV) Hydration Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Intravenous (IV) Hydration Therapy Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Service (Immune Boosters, Energy Boosters, Skin Care, Migraine, Others)
- 5.2.2. By Component (Medicated, Non-medicated)
- 5.2.3. By End-Use Industry (Hospitals & Clinics, Wellness Centers & Spas, Home Healthcare, Others)
- 5.2.4. By Company (2024)
- 5.2.5. By Region
5.3. Market Map

6. North America Intravenous (IV) Hydration Therapy Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Service
- 6.2.2. By Component
- 6.2.3. By End-Use Industry
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Intravenous (IV) Hydration Therapy Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Service
    - 6.3.1.2.2. By Component
    - 6.3.1.2.3. By End-Use Industry
- 6.3.2. Mexico Intravenous (IV) Hydration Therapy Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Service
    - 6.3.2.2.2. By Component
    - 6.3.2.2.3. By End-Use Industry
- 6.3.3. Canada Intravenous (IV) Hydration Therapy Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Service
    - 6.3.3.2.2. By Component
    - 6.3.3.2.3. By End-Use Industry

7. Europe Intravenous (IV) Hydration Therapy Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Service
- 7.2.2. By Component
- 7.2.3. By End-Use Industry
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Intravenous (IV) Hydration Therapy Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Service
    - 7.3.1.2.2. By Component
    - 7.3.1.2.3. By End-Use Industry
- 7.3.2. Germany Intravenous (IV) Hydration Therapy Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Service
    - 7.3.2.2.2. By Component
    - 7.3.2.2.3. By End-Use Industry
- 7.3.3. United Kingdom Intravenous (IV) Hydration Therapy Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Service
    - 7.3.3.2.2. By Component
    - 7.3.3.2.3. By End-Use Industry
- 7.3.4. Italy Intravenous (IV) Hydration Therapy Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Service
    - 7.3.4.2.2. By Component
    - 7.3.4.2.3. By End-Use Industry
- 7.3.5. Spain Intravenous (IV) Hydration Therapy Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Service
    - 7.3.5.2.2. By Component
    - 7.3.5.2.3. By End-Use Industry

8. Asia-Pacific Intravenous (IV) Hydration Therapy Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Service
- 8.2.2. By Component
- 8.2.3. By End-Use Industry
- 8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Intravenous (IV) Hydration Therapy Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Service
    - 8.3.1.2.2. By Component
    - 8.3.1.2.3. By End-Use Industry
- 8.3.2. India Intravenous (IV) Hydration Therapy Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Service
    - 8.3.2.2.2. By Component
    - 8.3.2.2.3. By End-Use Industry
- 8.3.3. South Korea Intravenous (IV) Hydration Therapy Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Service
    - 8.3.3.2.2. By Component
    - 8.3.3.2.3. By End-Use Industry
- 8.3.4. Japan Intravenous (IV) Hydration Therapy Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Service
    - 8.3.4.2.2. By Component
    - 8.3.4.2.3. By End-Use Industry
- 8.3.5. Australia Intravenous (IV) Hydration Therapy Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Service
    - 8.3.5.2.2. By Component
    - 8.3.5.2.3. By End-Use Industry

9. South America Intravenous (IV) Hydration Therapy Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Service
- 9.2.2. By Component
- 9.2.3. By End-Use Industry
- 9.2.4. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Intravenous (IV) Hydration Therapy Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Service
    - 9.3.1.2.2. By Component
    - 9.3.1.2.3. By End-Use Industry
- 9.3.2. Argentina Intravenous (IV) Hydration Therapy Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Service
    - 9.3.2.2.2. By Component
    - 9.3.2.2.3. By End-Use Industry
- 9.3.3. Colombia Intravenous (IV) Hydration Therapy Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Service
    - 9.3.3.2.2. By Component
    - 9.3.3.2.3. By End-Use Industry

10. Middle East and Africa Intravenous (IV) Hydration Therapy Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Service
- 10.2.2. By Component
- 10.2.3. By End-Use Industry
- 10.2.4. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Intravenous (IV) Hydration Therapy Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Service
    - 10.3.1.2.2. By Component
    - 10.3.1.2.3. By End-Use Industry
- 10.3.2. Saudi Arabia Intravenous (IV) Hydration Therapy Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Service
    - 10.3.2.2.2. By Component
    - 10.3.2.2.3. By End-Use Industry
- 10.3.3. UAE Intravenous (IV) Hydration Therapy Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Service
    - 10.3.3.2.2. By Component
    - 10.3.3.2.3. By End-Use Industry

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product

15. Competitive Landscape

15.1. Core IV Therapy, LLC
- 15.1.1. Business Overview
- 15.1.2. Company Snapshot
- 15.1.3. Products & Services
- 15.1.4. Financials (In case of listed companies)
- 15.1.5. Recent Developments
- 15.1.6. Key Personnel Details
- 15.1.7. SWOT Analysis
15.2. Cryojuvenate UK Ltd.
15.3. B. Braun Medical Inc.
15.4. Otsuka Pharmaceutical Co., Ltd.
15.5. NexGen Health Inc
15.6. JW Life Science Corporation
15.7. Amanta Healthcare Ltd
15.8. Baxter International Inc.
15.9. Drip Hydration Inc
15.10. Becton, Dickinson and Company